| Literature DB >> 29736038 |
Angelino T Tromp1, Michiel Van Gent1,2, Pauline Abrial3, Amandine Martin3, Joris P Jansen1, Carla J C De Haas1, Kok P M Van Kessel1, Bart W Bardoel1, Elisabeth Kruse1, Emilie Bourdonnay3, Michael Boettcher4, Michael T McManus4, Christopher J Day5, Michael P Jennings5, Gérard Lina3, François Vandenesch3, Jos A G Van Strijp1, Robert Jan Lebbink1, Pieter-Jan A Haas1, Thomas Henry6, András N Spaan7,8.
Abstract
The staphylococcal bi-component leukocidins Panton-Valentine leukocidin (PVL) and γ-haemolysin CB (HlgCB) target human phagocytes. Binding of the toxins' S-components to human complement C5a receptor 1 (C5aR1) contributes to cellular tropism and human specificity of PVL and HlgCB. To investigate the role of both leukocidins during infection, we developed a human C5aR1 knock-in (hC5aR1KI) mouse model. HlgCB, but unexpectedly not PVL, contributed to increased bacterial loads in tissues of hC5aR1KI mice. Compared to humans, murine hC5aR1KI neutrophils showed a reduced sensitivity to PVL, which was mediated by the toxin's F-component LukF-PV. By performing a genome-wide CRISPR-Cas9 screen, we identified CD45 as a receptor for LukF-PV. The human-specific interaction between LukF-PV and CD45 provides a molecular explanation for resistance of hC5aR1KI mouse neutrophils to PVL and probably contributes to the lack of a PVL-mediated phenotype during infection in these mice. This study demonstrates an unsuspected role of the F-component in driving the sensitivity of human phagocytes to PVL.Entities:
Mesh:
Substances:
Year: 2018 PMID: 29736038 DOI: 10.1038/s41564-018-0159-x
Source DB: PubMed Journal: Nat Microbiol ISSN: 2058-5276 Impact factor: 17.745